| Tag | Content |
|---|
EnhancerAtlas ID | HS175-11437 |
Organism | Homo sapiens |
Tissue/cell | SK-N-MC |
Coordinate | chr17:40506310-40508550 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EBF1 | MA0154.3 | chr17:40507642-40507656 | AGTCCCTTGGGGAT | - | 6.39 | | IRF1 | MA0050.2 | chr17:40508262-40508283 | AAAAAGAAAATAAAAGATAAA | - | 6.12 | | Zfx | MA0146.2 | chr17:40506429-40506443 | CCCGCCTCGGCCTC | + | 6.01 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_00115 | chr17:40506452-40508560 | Adipose_Nuclei | | SE_45847 | chr17:40505377-40508465 | Osteoblasts |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr17 | 40506920 | 40508469 | | chr17 | 40507981 | 40508031 | | chr17 | 40507032 | 40507177 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I042353 | chr17 | 40505378 | 40508560 |
|
Enhancer Sequence | CCGAGTAGCT GGGACTACAG GCATGCCCCA CCACGCCCGG CTAATTTTTG TATTTTTAGT 60
AGAGACGGGG TTTCACTATG TTGGCCAGGC TGGTCTCAAA CTCCTGACCT CGTGATCCGC 120
CCGCCTCGGC CTCCCAAACT GCTGGGAGTA CAAGCGCAAG TCATGGCACC CGGCCTGTGT 180
TATTTCTTAA AACAGAAACC AGCTAGTAGT TTTTTCCATA AAATTAAAGC ACCAGGCTGG 240
GCACAGTGGC TAACACCTAT AATCCCAGCA CTTTGGGAGG CTGAGGTGGG CGGATCACAA 300
GGTCAGGAGT TTGAGACCAG CCTAGCCAAT ATAGTGAAAC CCTGTCTCTA CTAAAAATTC 360
AAAAATTAGC CAGGCGTGGT GGTGGGCGCC TGTAGTCTCA GCTACTTGGG AGGCTGAGGC 420
AGGAGAATCG CTTGAACCTG GGAGGCAGAG GTTGCAGTGA GCCAAGATCG TGCCATTGCA 480
CTCCAGCCTG GGCAACAGAG TGAGACTCTG TCTCAAAAAA AAAAAAAAGA AGGCACCAGG 540
GCACCAACAA TGACTGATTT CATGTTTTAC TTCTTAGTCT AATCACCATA GGTAATACTT 600
TAATAGTTAT TCTACAGGGG AAAATAAAAG TATAACTTAA AGCCAAAGAC CAGGTAGTAT 660
TTTCAAGGAG AGAATATGCA AATACTTCCA TAGTCTTCTC CTTACAGGCT GCTTAGCTAC 720
AAACCATATT TAATTAACAG CAGTCACAGG AGATGACTAG CCAAAGTGTC TAGGAAAATC 780
ACTGCCAAGC AGCTTTACTG TAACTGTTTT ACTGGAAAAG ACCTCAAAGA GCCCATGTTA 840
TTTCACAATT TCAATTTTGG TTTTTCAAAT TACAAGTTAA TCTAAAGAAC TCCACTAAGT 900
TCTAACTACA TTACTTCATA TCTACGGAAT AATTCTAAGC CTGTGGGTTT TTAAAAAAAT 960
TTTATTAGAC ATTCTAGAAT TGGGCAACAC TTCATTCAAT GCCATAGGAT GAATGTTCTC 1020
CCCAAGCCTG TGACTTAATA ACTACTTCAT TGAGCCCCAG AACACACAAA GTTATCTGAG 1080
GAACAACTTG AGTGCCAACT ACCACTCTGG GTGCATAAGA GAGAAGACAA TTCATTACTC 1140
CATATAGGCT GCCTTAGGAC ATTATATGGG GCTCAATTCA AAGCATTTAC TCAGGTTAAG 1200
TCAGCAGATA GTAGATGCAC TGTACAAAGG CAAGGTGGGT GTAATCCTGT TTTCTATAAC 1260
TGAAGAGAAA AGAAAAAAAT GAAACAGCAA GTCATCAAAG ACTTTTTGGA CTTTTCAAAA 1320
CAGGAATTTC TCAGTCCCTT GGGGATAACC TACCAACAGC AAGTCATAAA ACAAATAACT 1380
ATTGTCTAAT TGGGAACTTA TTACCGTAAA GATGACTGAA AAAGTCTGTC CAAAGTTACA 1440
GTTCTCATTT ATATACTTGA ATCTAATGAA ACCAAAAGAT ATATTGAGAA ACGCAGTCAA 1500
GACCACTTAC AAAAGGGATT TACTACACAG CTTCATAAAA CTTTTTAAAG TTAAGACTTG 1560
TACTTCACAT CCATGCACTA GTGGATTTAC AACGAGGGTG AGGGAAGGCG GAAAGAGAGA 1620
CGAAAATCAG GCTCATACAA TAATCCAGAA CAGAAAGTGA TCTAAAGATA ACTTCTGTTC 1680
CACTTTGCAA TGTGTCATGA CATTTTCCTT TGGGTACCAC CTATACTTTT ATTATAAATA 1740
CATGCATTTT AAATAGAGCA TACCTGTGTT TTATCTGCTG CCTACACTAA CCTCTTCTTT 1800
GCTGTCAGGA AAGGCCCAGT GATCAAGGCA ACCAAAGTAT AAAGAAACAC AGAAGATTTC 1860
TTGCACTGAA TTCTATAGGA ACCAGTCCTT TTAAGAGATA TGTTTGAAAG ATTATAAAAT 1920
AATGTTCAAT GTGGAAAATT TAGAAAAATA TAAAAAAGAA AATAAAAGAT AAAAACATCC 1980
ATATCCCACC ATCCCACTAT GCAGAACAAA AACTGACATG TTGCCAGGTG TGGTGGTCTG 2040
TGACCCCAGC ACTTTGGGAG GCTGAGGGGG GAGGATCACT TGAGGCCAGG AAGTCAAGGC 2100
TGCAGTGAGC TGTGATTGCA CCACTGTACT CCAGCTTGGG TGACACAGCG AGACCCTGTC 2160
TCCGAAAAAA TAAAAATTGA CATGTTGATG TAATTCCTTT AAATCTATTT CAGAATGTGT 2220
TTGTGTGTGT GTATATATAT 2240
|
